CARDIOLITE

Cardiolite Adverse Events Reported to the FDA Over Time

How are Cardiolite adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Cardiolite, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Cardiolite is flagged as the suspect drug causing the adverse event.

Most Common Cardiolite Adverse Events Reported to the FDA

What are the most common Cardiolite adverse events reported to the FDA?

Nausea	24 (4.29%)
Rash	22 (3.94%)
Urticaria	18 (3.22%)
Headache	16 (2.86%)
Dysgeusia	15 (2.68%)
Dizziness	14 (2.5%)
Dyspnoea	12 (2.15%)
Vomiting	12 (2.15%)
Cough	11 (1.97%)
Pruritus	11 (1.97%)
Chest Pain	9 (1.61%)
	Show More
Flushing	8 (1.43%)
Hypersensitivity	8 (1.43%)
Pain In Extremity	8 (1.43%)
Pyrexia	8 (1.43%)
Swelling Face	8 (1.43%)
Tremor	7 (1.25%)
Anxiety	6 (1.07%)
Blood Pressure Increased	6 (1.07%)
Diarrhoea	6 (1.07%)
Paraesthesia	6 (1.07%)
Swollen Tongue	6 (1.07%)
Vision Blurred	6 (1.07%)
Chills	5 (.89%)
Hepatitis C	5 (.89%)
Hypotension	5 (.89%)
Injection Site Rash	5 (.89%)
Renal Failure	5 (.89%)
Abdominal Discomfort	4 (.72%)
Arthralgia	4 (.72%)
Back Pain	4 (.72%)
Cardiac Arrest	4 (.72%)
Feeling Abnormal	4 (.72%)
Procedural Complication	4 (.72%)
Wheezing	4 (.72%)
Abdominal Pain	3 (.54%)
Anaphylactic Reaction	3 (.54%)
Asthenia	3 (.54%)
Blood Glucose Increased	3 (.54%)
Cardiac Failure	3 (.54%)
Chest Discomfort	3 (.54%)
Circulatory Collapse	3 (.54%)
Coma	3 (.54%)
Convulsion	3 (.54%)
Drug Ineffective	3 (.54%)
Eye Swelling	3 (.54%)
Hypoaesthesia	3 (.54%)
Lethargy	3 (.54%)
Musculoskeletal Stiffness	3 (.54%)
Oedema Mouth	3 (.54%)
Pain	3 (.54%)
Post Procedural Complication	3 (.54%)
Rash Erythematous	3 (.54%)
Renal Failure Acute	3 (.54%)
Syncope	3 (.54%)
Throat Tightness	3 (.54%)
Angioedema	2 (.36%)
Arthropathy	2 (.36%)
Blister	2 (.36%)
Blood Pressure Decreased	2 (.36%)
Body Temperature Increased	2 (.36%)
Bradycardia	2 (.36%)
Burning Sensation	2 (.36%)
Cardio-respiratory Arrest	2 (.36%)
Chemical Injury	2 (.36%)
Disorientation	2 (.36%)
Drug Hypersensitivity	2 (.36%)
Dysarthria	2 (.36%)
Erythema	2 (.36%)
Fatigue	2 (.36%)
Heart Rate Irregular	2 (.36%)
Hyperhidrosis	2 (.36%)
Hypertension	2 (.36%)
Hypoglycaemia	2 (.36%)
Hypokalaemia	2 (.36%)
Infusion Site Pain	2 (.36%)
Injection Site Ulcer	2 (.36%)
Kidney Infection	2 (.36%)
Lip Swelling	2 (.36%)
Loss Of Consciousness	2 (.36%)
Malaise	2 (.36%)
Monoplegia	2 (.36%)
Muscle Spasms	2 (.36%)
Muscular Weakness	2 (.36%)
Oral Pruritus	2 (.36%)
Orthostatic Hypotension	2 (.36%)
Renal Disorder	2 (.36%)
Renal Pain	2 (.36%)
Respiratory Arrest	2 (.36%)
Respiratory Failure	2 (.36%)
Skin Disorder	2 (.36%)
Skin Exfoliation	2 (.36%)
Splenic Injury	2 (.36%)
Tachycardia	2 (.36%)
Tongue Disorder	2 (.36%)
Unresponsive To Stimuli	2 (.36%)
Weight Increased	2 (.36%)
Abdominal Pain Upper	1 (.18%)
Abnormal Faeces	1 (.18%)
Accidental Exposure	1 (.18%)
Acidosis	1 (.18%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Cardiolite, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Cardiolite is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Cardiolite

What are the most common Cardiolite adverse events reported to the FDA?

Neurological	60 (10.73%)
Epidermal And Dermal Conditions	58 (10.38%)
Gastrointestinal Signs	50 (8.94%)
Respiratory	36 (6.44%)
Angiedema And Urticaria	21 (3.76%)
Headaches	17 (3.04%)
Musculoskeletal And Connective Tiss...	17 (3.04%)
Administration Site Reactions	15 (2.68%)
Cardiac Arrhythmias	15 (2.68%)
Cardiac And Vascular Investigations	14 (2.5%)
Allergic Conditions	13 (2.33%)
	Show More
Renal Disorders	11 (1.97%)
Vascular	11 (1.97%)
Decreased And Nonspecific Blood Pre...	10 (1.79%)
Movement Disorders	10 (1.79%)
Body Temperature Conditions	8 (1.43%)
Oral Soft Tissue Conditions	8 (1.43%)
Tongue Conditions	8 (1.43%)
Vision	8 (1.43%)
Anxiety Disorders	7 (1.25%)
Gastrointestinal Motility And Defec...	7 (1.25%)
Joint	7 (1.25%)
Procedural And Device Related Injur...	7 (1.25%)
Therapeutic And Nontherapeutic Effe...	7 (1.25%)
Bronchial Disorders	5 (.89%)
Heart Failures	5 (.89%)
Metabolic, Nutritional And Blood Ga...	5 (.89%)
Viral Infectious	5 (.89%)
Infections - Pathogen Unspecified	4 (.72%)
Injuries	4 (.72%)
Muscle	4 (.72%)
Physical Examination Topics	4 (.72%)
Deliria	3 (.54%)
Electrolyte And Fluid Balance Condi...	3 (.54%)
Eye	3 (.54%)
Glucose Metabolism Disorders	3 (.54%)
Seizures	3 (.54%)
Urinary Tract Signs	3 (.54%)
Acid-base	2 (.36%)
Bone And Joint Injuries	2 (.36%)
Chemical Injury And Poisoning	2 (.36%)
Medication Errors	2 (.36%)
Ocular Infections, Irritations And ...	2 (.36%)
Skin Appendage Conditions	2 (.36%)
Skin Vascular Abnormalities	2 (.36%)
Upper Respiratory Tract Disorders	2 (.36%)
Vascular Hypertensive	2 (.36%)
Water, Electrolyte And Mineral	2 (.36%)
Ancillary Infectious Topics	1 (.18%)
Cardiac Disorder Signs	1 (.18%)
Depressed Mood Disorders	1 (.18%)
Fatal Outcomes	1 (.18%)
Hearing	1 (.18%)
Inner Ear And Viiith Cranial Nerve	1 (.18%)
Investigations, Imaging And Histopa...	1 (.18%)
Lifestyle Issues	1 (.18%)
Lower Respiratory Tract Disorders	1 (.18%)
Mental Impairment	1 (.18%)
Neonatal Respiratory	1 (.18%)
Ocular Neuromuscular	1 (.18%)
Platelet	1 (.18%)
Reproductive Organ And Breast Inves...	1 (.18%)
Salivary Gland Conditions	1 (.18%)
Sleep Disorders	1 (.18%)
Spleen, Lymphatic And Reticulendoth...	1 (.18%)
Urolithiases	1 (.18%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Cardiolite, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Cardiolite is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.